American Well Corporation reports developments for Amwell, a SaaS-based software platform for technology-enabled healthcare used by payers and health systems. Company updates center on quarterly and annual operating results, business reviews, investor conference participation, and equity-compensation actions such as inducement-plan grants.
The Amwell platform combines software and services that support virtual care programs across the care continuum, including virtual primary care, urgent care, clinical partner programs, scheduling, provider workflows, prescribing, and treatment-guideline reference tools. News about AMWL commonly connects these platform capabilities with payer and health system relationships, partner clinical programs, and management commentary on technology-enabled care delivery.
Amwell (NYSE: AMWL) said CFO and COO Mark Hirschhorn will participate in the TD Cowen 46th Annual Health Care Conference in Boston on March 3, 2026, including a fireside chat at 3:10 p.m. ET.
An audio webcast of the fireside chat will be available at the company investor website.
Amwell (NYSE: AMWL) announced on February 18, 2026 a grant of 61,559 RSUs to one new employee as a material inducement to employment. The grant was approved by the Compensation Committee under Amwell’s Inducement Plan and relies on the NYSE employment inducement exemption.
The RSUs vest 25% on the first anniversary of the grant, with the remaining 75% vesting in equal pro rata increments every three months thereafter over three years (beginning the first calendar day of the month after the three-month period following the Initial Vesting Date).
Amwell (NYSE: AMWL) announced fourth-quarter and full-year 2025 financial results and will host a conference call today, Feb 12, 2026, at 5:00 p.m. ET.
The company said investors can view the earnings release and access a live audio webcast at the provided link; a replay will be available for ~90 days on the investor site.
Amwell (NYSE: AMWL) will report fourth quarter and full year 2025 operating results after market close on Thursday, Feb. 12, 2026. Management will host a live conference call and webcast at 5:00 p.m. ET to review results and provide a business update.
The full earnings release and live audio webcast will be available in the company's Investors section; a webcast replay will remain available at investors.amwell.com for approximately 90 days.
Amwell (NYSE: AMWL) announced financial results for the third quarter ended September 30, 2025. The company said its full third quarter earnings report is available at investors.amwell.com.
Amwell will host a conference call to discuss results on November 4, 2025 at 5:00 p.m. ET; the call is accessible via live audio webcast at https://edge.media-server.com/mmc/p/63sb3bwu. A webcast replay will be available for approximately 90 days at investors.amwell.com.
Amwell (NYSE: AMWL) will report third quarter 2025 operating results after market close on Tuesday, Nov. 4, 2025. Management will host a live conference call and webcast at 5:00 p.m. ET to review results and provide a business update. The full earnings report and live audio webcast will be available in the company's Investors section, and a webcast replay will remain at investors.amwell.com for about 90 days.
Company executives will attend investor conferences: Mark Hirschhorn, CFO and COO, will hold one-on-one meetings at the UBS Global Healthcare Conference on Nov. 11 in Palm Beach Gardens, FL, and will join a virtual panel titled “Transforming a Sick-Care System into a Health-Care System” at the BTIG Digital Health Forum on Nov. 24 at 8:00 a.m. ET; an audio webcast of the fireside chat will be posted at investors.amwell.com.
Amwell (NYSE: AMWL), a technology-enabled care platform provider, has granted 76,198 Restricted Stock Units (RSUs) of Class A common stock to two new employees as employment inducements. The RSUs follow a four-year vesting schedule, with 25% vesting after one year and the remaining 75% vesting quarterly over three years.
The grants were approved by Amwell's Compensation Committee under the company's Inducement Plan, complying with NYSE's Listed Company Manual Rule 303A.08.
Amwell (NYSE: AMWL), a leading SaaS-based healthcare platform provider, has announced its financial results for the second quarter ended June 30, 2025. The company will discuss these results during a conference call scheduled for 5 p.m. ET on August 5, 2025.
The earnings report is available on the company's investor relations website, and a live audio webcast of the conference call will be accessible online. A replay of the webcast will remain available for approximately 90 days on the investor relations website.
Amwell (NYSE: AMWL) has secured an extension of its Digital First contract as part of a Leidos-led partnership to continue powering the Military Health System's (MHS) digital transformation. The platform serves approximately 9.6 million beneficiaries across the Department of Defense enterprise, including active-duty service members, families, and retirees.
The successfully deployed platform has replaced MHS Video Connect and is fully integrated with MHS GENESIS electronic health record. Key achievements include nearly tripling virtual visits, expansion to U.S. Coast Guard and Military Entrance Processing Command, and enabling successful virtual visits from combat zones to U.S. military hospitals.
Amwell (NYSE: AMWL), a leading SaaS-based healthcare technology platform provider, has scheduled its second quarter 2025 earnings release for August 5 after market close. Management will host a conference call and webcast at 5 p.m. ET to discuss results and provide business updates.
Additionally, company executives will participate in two upcoming investor conferences: CFO/COO Mark Hirschhorn will attend the Wells Fargo Healthcare Conference on September 4 in Boston, while Chairman/CEO Ido Schoenberg and Hirschhorn will join the Morgan Stanley Global Healthcare Conference on September 9 in New York, including a fireside chat at 2:35 p.m. ET.